Oral rhabdomyosarcoma: A review

Area of Science:

• Oncology
• Pediatric Oncology
• Surgical Oncology

Background:

• Rhabdomyosarcoma (RMS) is a rare malignant soft tissue neoplasm originating from primitive mesenchymal cells.
• Head and neck RMS accounts for approximately 35% of all RMS cases and is common in children, adolescents, and young adults.
• Bone invasion is frequently observed in head and neck RMS due to the tumor's infiltrative growth pattern.

Purpose of the Study:

• To emphasize the etiopathogenesis and molecular relevance of head and neck Rhabdomyosarcoma.
• To highlight the treatment modalities and prognostic factors for Rhabdomyosarcoma.
• To discuss the challenges posed by bone invasion in head and neck sarcomas.

Main Methods:

• Review of existing literature on Rhabdomyosarcoma.
• Analysis of treatment strategies including radical excision, radiotherapy, and chemotherapy.
• Discussion of tumor behavior, including infiltrative growth and recurrence patterns.

Main Results:

• Radical excision is the primary treatment for Rhabdomyosarcoma, often combined with radiotherapy.
• Adjunct combination chemotherapy is believed to significantly improve prognosis.
• Inadequately treated tumors have a high recurrence rate and exhibit infiltrative growth.

Conclusions:

• Head and neck Rhabdomyosarcoma requires aggressive, multimodal treatment to improve patient outcomes.
• Early and adequate treatment is crucial to prevent tumor recurrence and manage bone invasion.
• Further research into the molecular aspects of Rhabdomyosarcoma may lead to more targeted therapies.